iodolisuride

123I isomer used in in-vivoSPECT imaging of D2 receptor

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Parkinson Disease (Parkinson's Disease) 12/01/1997 - "The aim of this study was to assess the correlation between the functional integrity and density of striatal dopaminergic receptors and clinical data in 15 de-novo patients with idiopathic Parkinson's disease by single photon emission tomography (SPET) using 2-[123I]-iodolisuride (ILIS), a tracer based on the D2-dopamine receptor agonist lisuride. " 11/01/2001 - "Iodolisuride is a good specific D2 receptor ligand for SPECT and complements specific clinical criteria for the diagnosis of Parkinson's disease and differentiation between different extrapyramidal disorders."
2.	Paralysis (Palsy) 08/01/1992 - "In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy."
3.	Basal Ganglia Diseases (Basal Ganglia Disease) 11/01/2001 - "Iodolisuride is a good specific D2 receptor ligand for SPECT and complements specific clinical criteria for the diagnosis of Parkinson's disease and differentiation between different extrapyramidal disorders."